Imperial Valley News Center
The business of dying
- Details
- Written by John Grimaldi
Imperial, California - Death is big business in Japan and the competition is fierce, says the Association of Mature American Citizens. The population over there is aging at a quickening pace, and so is the demand for funerals and funeral services.
Farmer sentiment rises, but opinions split over potential impact of aid package
- Details
- Written by Kami Goodwin
Chicago, Illinois - Agricultural producer sentiment increased modestly in August after dipping sharply in July, according to the latest Purdue University/CME Group Ag Economy Barometer reading. The barometer, which is based on a monthly survey of 400 agricultural producers from across the country, had an August reading of 129, 12 points higher than July but still well below readings from May and June.
Genetics and pollution drive severity of asthma symptoms
- Details
- Written by Robin Arnette
Washington, DC - Asthma patients, with a specific genetic profile, exhibit more intense symptoms following exposure to traffic pollution, according to researchers at the National Institutes of Health and collaborators. The study appeared online in Scientific Reports.
Novel intervention halves rate of death among people living with HIV who inject drugs
- Details
- Written by Laura S. Leifman
Washington, DC - An intervention designed to facilitate treatment for HIV and substance use was associated with a 50 percent reduction in mortality for people living with HIV who inject illicit drugs, a study has found. In addition, the people who received the intervention were nearly twice as likely to report being in treatment for HIV and substance use after one year as those who received their national standard of care. They also were about twice as likely to have suppressed their HIV to undetectable levels after one year. The intervention consisted of psychosocial counseling along with guidance and support navigating the healthcare system. These findings were reported today in the journal The Lancet.
Study finds multiple sclerosis drug slows brain shrinkage
- Details
- Written by Barbara McMakin
Washington, DC - Results from a clinical trial of more than 250 participants with progressive multiple sclerosis (MS) revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study also showed that the main side effects of ibudilast were gastrointestinal and headaches. The study was supported by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, and published in the New England Journal of Medicine.
Event registration opens today for National Drug & Alcohol Facts Week
- Details
- Written by NIDA
Washington, DC - The National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) announced today that event registration is open for the next National Drug & Alcohol Facts Week (NDAFW), to be held on Jan. 22-27, 2019. NDAFW is an annual, week-long series of educational events that link teens with scientific experts to SHATTER THE MYTHS about substance use and addiction. NIDA and NIAAA are both part of the National Institutes of Health.
Page 1118 of 3785